Mairs & Power Inc’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.47M Sell
24,200
-738
-3% -$43K 0.02% 136
2025
Q4
$1.35M Sell
24,938
-1,454
-6% -$69.9K 0.01% 137
2025
Q3
$1.19M Sell
26,392
-450
-2% -$21K 0.01% 139
2025
Q2
$1.24M Buy
26,842
+282
+1% +$13.8K 0.01% 132
2025
Q1
$1.62M Buy
26,560
+398
+2% +$23.2K 0.02% 120
2024
Q4
$1.48M Buy
26,162
+180
+0.7% +$10.1K 0.01% 121
2024
Q3
$1.34M Sell
25,982
-3,400
-12% -$159K 0.01% 128
2024
Q2
$1.22M Sell
29,382
-17,115
-37% -$766K 0.01% 128
2024
Q1
$2.52M Sell
46,497
-6,805
-13% -$347K 0.02% 110
2023
Q4
$2.73M Buy
53,302
+3,200
+6% +$168K 0.03% 112
2023
Q3
$2.91M Sell
50,102
-11,681
-19% -$716K 0.03% 105
2023
Q2
$3.95M Sell
61,783
-16,242
-21% -$1.09M 0.04% 98
2023
Q1
$5.41M Sell
78,025
-1,082
-1% -$76.3K 0.06% 91
2022
Q4
$5.69M Sell
79,107
-570
-0.7% -$43K 0.07% 94
2022
Q3
$5.66M Buy
79,677
+11,738
+17% +$851K 0.07% 90
2022
Q2
$5.23M Sell
67,939
-832
-1% -$63.4K 0.06% 92
2022
Q1
$5.02M Sell
68,771
-1,668
-2% -$112K 0.05% 96
2021
Q4
$4.39M Sell
70,439
-6,666
-9% -$391K 0.04% 102
2021
Q3
$4.56M Sell
77,105
-5,530
-7% -$364K 0.05% 100
2021
Q2
$5.52M Sell
82,635
-14,717
-15% -$960K 0.05% 96
2021
Q1
$6.15M Sell
97,352
-6,522
-6% -$406K 0.06% 93
2020
Q4
$6.44M Sell
103,874
-4,026
-4% -$248K 0.07% 90
2020
Q3
$6.5M Sell
107,900
-4,372
-4% -$263K 0.08% 84
2020
Q2
$6.6M Sell
112,272
-36,341
-24% -$2.17M 0.09% 86
2020
Q1
$8.28M Sell
148,613
-73,844
-33% -$4.51M 0.12% 78
2019
Q4
$14.3M Sell
222,457
-6,725
-3% -$385K 0.16% 70
2019
Q3
$11.6M Sell
229,182
-8,350
-4% -$392K 0.14% 77
2019
Q2
$10.8M Sell
237,532
-11,824
-5% -$551K 0.13% 79
2019
Q1
$11.9M Sell
249,356
-6,000
-2% -$299K 0.14% 74
2018
Q4
$13.3M Sell
255,356
-1,175
-0.5% -$63.1K 0.18% 64
2018
Q3
$15.9M Sell
256,531
-22,413
-8% -$1.33M 0.19% 62
2018
Q2
$15.4M Sell
278,944
-12,958
-4% -$700K 0.19% 66
2018
Q1
$18.5M Sell
291,902
-40,690
-12% -$2.62M 0.23% 62
2017
Q4
$20.4M Sell
332,592
-7,253
-2% -$454K 0.24% 58
2017
Q3
$21.7M Sell
339,845
-3,198
-0.9% -$187K 0.26% 59
2017
Q2
$19.1M Sell
343,043
-1,237
-0.4% -$67.3K 0.23% 60
2017
Q1
$18.7M Buy
344,280
+3,458
+1% +$190K 0.23% 61
2016
Q4
$19.9M Buy
340,822
+10,000
+3% +$547K 0.26% 59
2016
Q3
$17.8M Buy
330,822
+45,074
+16% +$2.9M 0.24% 62
2016
Q2
$21M Sell
285,748
-170
-0.1% -$12K 0.28% 55
2016
Q1
$18.3M Sell
285,918
-1,145
-0.4% -$72.2K 0.26% 56
2015
Q4
$19.7M Buy
287,063
+2,489
+0.9% +$164K 0.3% 57
2015
Q3
$16.8M Buy
284,574
+1,591
+0.6% +$101K 0.26% 60
2015
Q2
$18.8M Sell
282,983
-10,787
-4% -$711K 0.27% 57
2015
Q1
$18.9M Sell
293,770
-1,265
-0.4% -$79.2K 0.26% 55
2014
Q4
$17.4M Buy
295,035
+600
+0.2% +$33.8K 0.24% 59
2014
Q3
$15.1M Buy
294,435
+896
+0.3% +$44.8K 0.22% 61
2014
Q2
$14.2M Sell
293,539
-3,300
-1% -$163K 0.2% 62
2014
Q1
$15.4M Sell
296,839
-3,917
-1% -$208K 0.23% 60
2013
Q4
$16M Sell
300,756
-4,200
-1% -$214K 0.25% 58
2013
Q3
$14.1M Sell
304,956
-22,300
-7% -$979K 0.24% 60
2013
Q2
$14.6M Buy
+327,256
New +$14.2M 0.28% 58

Other funds holding BMY

Mairs & Power Inc's BMY Position: Q1 2026 in Review

Mairs & Power Inc reduced its Bristol-Myers Squibb (BMY) stake by 3% in Q1 2026, selling an estimated $43K and leaving 24,200 shares worth $1.47M. The position accounts for 0.02% of the portfolio, ranked #136.

Mairs & Power Inc first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.7M in Q3 2017. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Mairs & Power Inc held 24,200 shares of Bristol-Myers Squibb worth $1.47M as of Q1 2026.
  • Mairs & Power Inc sold 738 Bristol-Myers Squibb shares in Q1 2026, an estimated $43K.
  • Bristol-Myers Squibb made up 0.02% of Mairs & Power Inc's portfolio in Q1 2026, its #136 holding.
  • Mairs & Power Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Mairs & Power Inc's Bristol-Myers Squibb position peaked at $21.7M in Q3 2017.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Mairs & Power Inc's 13F filing for Q1 2026, filed 14 May 2026.